Nishinomiya
Japan
Case Report
Anti-Cancer Drug Nab-Paclitaxel May Exacerbate Corneal Epithelial
Disorder
Author(s): Yuka Hosotani, Hiroto Ishikawa, Kumiko Miyanaga and Fumi GomiYuka Hosotani, Hiroto Ishikawa, Kumiko Miyanaga and Fumi Gomi
Purpose: To report 2 cases of corneal disorder after cancer treatment with nab paclitaxel.
Methods: Retrospective review of 2 cases.
Case presentation: Case 1 was a 55-year-old female who presented with blurred vision. She underwent cancer treatment in the form of combination therapy with nab-paclitaxel, trastuzumab and pertuzumab for breast cancer 2 weeks before. An ophthalmoscopic examination showed an atypical corneal epithelium invasion in both eyes. The corneal disorder was resolved following discontinuation of nab-paclitaxel. Case 2 had a pancreatic cancer and she presented with an atypical corneal epithelium invasion in both eyes after treatment with S-1 and gemcitabine hydrochloride. The corneal disorder might be caused by S-1, so S-1 treatment was replaced by nab-paclitaxel. The corneal disorder improved t.. Read More»
DOI:
10.4172/2165-7920.10001002
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report